National Institute for Health and Care Research An introduction to complex and innovative clinical trials: Emma Lowe, Department of Health and Social Care
View the accessible transcript of this podcast
Emma Lowe talks to Professor Allan Gaw about the design and delivery of complex and innovative design clinical trials.
In this episode they discuss what the term 'complex innovative design' (or CID) means in relation to clinical research. Emma explains that it focuses on 'how the research is done' as opposed to 'why it is being done'. She also highlights some of the benefits of delivering research in new and innovative ways, compared to the traditional randomised controlled trial (RCT).
The Life Sciences Sector Deal published on 5 December 2018 sets out the Government’s commitment to consolidate the UK as a world-leader in delivering complex and innovative trials. In relation to this, Emma describes some of the activities undertaken by the National Institute for Health Research (NIHR) to:
1) showcase UK expertise in designing and delivering complex and innovative design trials and;
2) to promote understanding of complex and innovative design trials across the UK clinical research workforce.
To find out more about how the NIHR supports complex and innovative design trials, visit the NIHR website: www.nihr.ac.uk/innovative-trials
This podcast is part of our pre-pandemic series of podcasts on Complex and Innovative Design (CID) trials. You can listen to all our full collection of #ComplexInnovativeDesign trial podcasts on our website.